A sample report by Clearstate

Unparalleled depth and actionable intelligence about Thailand’s in-vitro diagnostics market

The Centralised Diagnostics (CDx) market in Thailand experienced an overall growth of 10.7% from 2021 to 2022, as the market began its recovery from the COVID-19 pandemic, emerging as the leading contributor to the overall IVD market at the end of this period. But, what’s the outlook for the country’s diagnostic  industry, and which segments should IVD  companies focus on or avoid in the country?

This sample report offers a glance at the granular insights and in-depth analysis awaiting you in the full Segment Trend Report about Thailand’s IVD market.